Company Encyclopedia
View More
name
Cartica Acquisition
CITE.US
Cartica Acquisition Corp does not have any significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify and complete a business combination in the technology sector. Cartica Acquisition Corp was incorporated in 2021 and is based in New York, New York.
1.124 T
CITE.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Cartica Acquisition Corp. Held Extraordinary General Meeting

    Cartica Acquisition Corp. held an Extraordinary General Meeting on December 4, 2025, where shareholders approved the Business Combination Agreement and related transactions, including a merger with Merger Sub and Nidar.

    Reuters·
    US
    CITEU
    0.00%
    US
    CITE
    0.00%
    Reuters·
    US
    CITEU
    0.00%
    US
    CITE
    0.00%

    Cartica Acquisition Corp. to Merge with Nidar Infrastructure Limited

    Cartica Acquisition Corp. and Nidar Infrastructure Limited have agreed to a two-step merger process. Yotta Data and Cloud Limited will merge with Cartica, making Cartica a subsidiary of Nidar. Subsequently, Cartica will merge into Nidar, which will be the surviving entity. A forward purchase agreement allows Harraden Circle Investors, LP to buy up to 900,000 Cartica Class A shares in the open market before the transaction closes.

    Reuters·
    US
    CITEU
    0.00%
    US
    CITE
    0.00%
    Reuters·
    US
    CITEU
    0.00%
    US
    CITE
    0.00%

    Cartica Acquisition Corp Announces Change of Date of Extraordinary General Meeting of Shareholders

    Cartica Acquisition Corp has postponed its extraordinary general meeting of shareholders, originally set for November 28, 2025, to December 4, 2025. The meeting is to approve proposals related to a business combination with Nidar Infrastructure Limited and Yotta Data and Cloud Limited. The postponement allows time for additional disclosures in the proxy statement. The deadline for redemption demands is extended to December 2, 2025. Shareholders are encouraged to submit or change their proxies. More details are available in the proxy statement/prospectus.

    fidelity·
    US
    CITEU
    0.00%
    US
    CITE
    0.00%
    fidelity·
    US
    CITEU
    0.00%
    US
    CITE
    0.00%

    20:30 ET SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-HOUS, CRTAF, BRY, and AKRO

    Monteverde & Associates PC, a top class action firm, is investigating several mergers: Anywhere Real Estate's sale to Compass Inc., Cartica Acquisition's merger with Nidar Infrastructure, Berry Corporation's sale to California Resources, and Akero Therapeutics' sale to Novo Nordisk. The firm, known for recovering millions for shareholders, is urging shareholders to act before upcoming votes. The investigations focus on ensuring fair shareholder treatment in these transactions.

    prnewswire·
    US
    BRY
    +0.58%
    US
    AKRO
    -0.27%
    US
    CITEU
    0.00%
    prnewswire·
    US
    BRY
    +0.58%
    US
    AKRO
    -0.27%
    US
    CITEU
    0.00%

    17:30 ET $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS

    Class Action Attorney Juan Monteverde of Monteverde & Associates PC is investigating mergers involving Cartica Acquisition Corp. (CRTAF), Akero Therapeutics (AKRO), Adverum Biotechnologies (NIC), and Barinthus Biotherapeutics (BRNS). Shareholder votes are scheduled for November 28, 2025, December 2, 2025, and December 8, 2025, respectively. The firm has a successful track record in recovering funds for shareholders and offers free consultations for those concerned about these transactions.

    prnewswire·
    US
    ADVM
    +0.60%
    US
    BRNS
    +3.74%
    US
    AKRO
    -0.27%
    prnewswire·
    US
    ADVM
    +0.60%
    US
    BRNS
    +3.74%
    US
    AKRO
    -0.27%
    © 2025 Longbridge｜Disclaimer